Berma Research Group

Hialeah, Florida 33016

0 studies enrolling now · 16 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Alzheimer's Disease, Generalized Anxiety Disorder, Mild Cognitive Impairment, Schizophrenia

Studies at this site

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Stopped early
POC Study in Partially Responsive Generalized Anxiety Disorder — Stopped early
CATIE-Alzheimer's Disease Trial — Completed
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease — Completed
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type — Completed
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease — Completed
Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease — Completed
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease — Completed
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia — Completed
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) — Completed
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease — Status unconfirmed